Navigation Links
Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis
Date:12/2/2009

sition as it explores additional, first-in-class opportunities for the candidate drug and other compounds for the topical treatment of dermatological infections, such as impetigo and infected wounds and burns."

The rapid resistance development by microbes limits the use of classical antibiotics for indications such as atopic dermatitis, especially for topical applications. DermaGen's AMP is derived from natural endogenous human proteins and there is low probability that it will induce resistance as it lack a specific molecular target on bacteria and other microbes. Anti-infective treatments represent the most important component of the global dermatology market, accounting for 31% of total market value, approximately USD 4 billion.

Conny Bogentoft, CEO of Karolinska Development, said, "Pergamum and its Operating Units form an important part of the Karolinska Development portfolio. They represent a strong offering in dermatology and wound healing markets with products targeting indications with significant unmet medical needs. It is encouraging to see the progress they are making in their clinical development programs."

About DermaGen

DermaGen AB is a specialty pharmaceutical company and world leader in the research and development of endogenous antimicrobial peptides. Founded in 2004, DermaGen focuses on the development of topically applied products for the prevention and treatment of bacterial and fungal skin infections. Novel antimicrobial peptides are modified to increase their potency and stability, facilitating the development of pharmaceutical products that fulfill unmet medical needs and significantly improve quality of life for patients. DermaGen partners with leading international pharmaceutical companies in the dermatological field to ensure rapid and cost-efficient development. The company is based in Lund, Sweden and is part of the Pergamum group of companies.

'/>"/>

SOURCE DermaGen AB
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DermaGen AB Receives Over 1 Million Euros From a New Share Issue
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Spherix Reports Second Quarter Earnings
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015 The Judicial Panel ... week about whether to centralize Inferior vena cava (IVC) ... IVC manufacturer, Cook Medical, have already been centralized by ... implanted in patients at risk for a pulmonary embolism. ... traveling to the lungs. Claims against Bard and Cook ...
(Date:7/29/2015)... July 29, 2015 Pulmatrix, Inc., (NASDAQ: ... August 6, 2015 at 10:45 am EDT. As ... Chief Executive Officer, will review Pulmatrix,s strategic plan ... of inhaled therapeutics based on their proprietary iSPERSE™ ... Thursday, August 6, 2015 Time:    10:45 am EDT ...
(Date:7/29/2015)... 29, 2015  Fifty groups representing 500,000 patients, doctors, ... to launch the AllTrials campaign in the US. The ... and future, to be registered and the results from ... Ben Goldacre explains: "Patients want the treatments that ... on what works. Unfortunately, we now know that around ...
Breaking Medicine Technology:IVC filter litigation continues; law firm provides free information to IVC filter patients 2Pulmatrix to Webcast Investor Presentation and Provide Update on Pipeline of Inhaled Therapeutics August 6th 2Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3
... -USPTO to grant patent covering the anti-HCV drug PSI-6130 and its ... ... N.J., June 26 Pharmasset, Inc.,(Nasdaq: VRUS ) announced that ... Allowance for patent application Serial No.,10/828,753 titled, "Modified Fluorinated Nucleoside Analogues," ...
... Life Sciences,Holdings, Inc. (Nasdaq: ADLS ), ... and commercialization of novel drugs in the,therapeutic ... today,announced that the Journal of Antimicrobial Chemotherapy ... Isolates of the USA300 clone of MRSA,to ...
Cached Medicine Technology:Pharmasset Receives Notice of Allowance 2Pharmasset Receives Notice of Allowance 3Pharmasset Receives Notice of Allowance 4Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA) 2Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA) 3Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA) 4Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA) 5
(Date:7/29/2015)... Minneapolis, Minnesota (PRWEB) , ... July 29, 2015 , ... ... The Sofia Fund, which invests in women-led, growth companies and is led by a ... Investors have responded positively, and voted with their dollars to be a part ...
(Date:7/29/2015)... , ... July 29, 2015 , ... CanAm Enterprises, LLC ... USCIS over the past month! I-829 approvals have been granted to investors in four ... Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the Valley Forge Convention Center ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired by ... in March, Steven W. Meier M.D., a prominent orthopedic surgeon and regenerative medicine ... with demonstrated financial need. , “We are thrilled for this opportunity to offer ...
(Date:7/29/2015)... ... ... Employee Fiduciary, LLC announces the launch of its new, online Financial Advisor ... administered, years in business, and credentials of all Employee Fiduciary financial advisor partners ... Fiduciary. A search can be done by zip code so a plan sponsor can ...
(Date:7/29/2015)... ... 29, 2015 , ... TransFlip is an all new dynamic transition pack for ... FCPX, these transitions are easy to apply and modify for any skill-level user. TransFlip ... 60 preset styles, kinetic flipping panel animations are just a few clicks away. , ...
Breaking Medicine News(10 mins):Health News:Sofia Fund Surpasses Investor Goals 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2
... ... effective in aiding weight loss. Users say it helps them lose up to 40 ... ... of "super chocolate" has been fast increasing popularity among international models and athletes as ...
... (embargo: 6 May, 16:45 CEST) , J. Hicks, USA, ... from very small samples , Researchers have developed a powerful ... The breakthrough allows them to study in fine detail the ... receptor status of HER2+ breast cancer correlates with response to ...
... of Pediatrics, Global Health and Epidemiology & Biostatistics ... has been selected by the J. William Fulbright ... Fulbright Scholarship. Beginning in August 2010, Dr. Mandalakas ... in collaboration with Stellenbosch University to study the ...
... ... ... CosmoCom the global leader in Contact Center Consolidation 2.0, announced that its healthcare contact ... (LISA). Presented by the Long Island Software and Technology Network (LISTnet), the LISA recognizes ...
... ... ... for the Skinny on Willpower! The publishing industry is in the midst of a revolutionary change, ... The Skinny On series. The series, recent hit, The Skinny On Willpower , addresses ...
... Urns.com Offers New Biodegradable Urns ... More Give People The Option To Have More A Eco-Friendly Funeral. , ... Goleta, CA (PRWEB) May 6, 2010 –- When a loved one ... where those left behind need to consider not only the wishes of the deceased, but also ...
Cached Medicine News:Health News:Super Fat-Melting Chocolate Recipe Revealed 2Health News:Super Fat-Melting Chocolate Recipe Revealed 3Health News:IMPAKT Breast Cancer Conference press program 2Health News:CWRU global TB expert receives prestigious Fulbright Scholar Award 2Health News:CWRU global TB expert receives prestigious Fulbright Scholar Award 3Health News:CosmoCom Wins Software Award for CosmoHealth 2Health News:CosmoCom Wins Software Award for CosmoHealth 3Health News:Readers and Reviewers Rave about 'The Skinny On Willpower' 2Health News:Readers and Reviewers Rave about 'The Skinny On Willpower' 3Health News:Readers and Reviewers Rave about 'The Skinny On Willpower' 4Health News:Urns.com Announces Urns As An Eco Friendly Burial Alternative 2
For vacuum-driven processing of spin columns; Reduced sample handling and accelerated processing; Parallel sample processing using QIAGEN spin columns; Easy cleaning of internal components by simpl...
Inquire...
... The Perfect Single Vac ... one 96-well plate in 30 ... with an "open/closed" switch and ... for easy operation. contains vacuum ...
... has been designed for use with Bioneer's ... can handle 96 samples (Plasmid DNA, Genomic ... and purification. While conventional kits use centrifugal ... BioVac 96 Vacuum Manifold uses vacuum pressure ...
Medicine Products: